IONIS PHARMACEUT reported $142K in Ordinary Share Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Alnylam Pharmaceuticals ALNY:US $ 1.21M 0M
Arrowhead Research ARWR:US $ 198K 0
Astellas Pharma 4503:JP Y 103001M 0M
Biomarin Pharmaceutical BMRN:US $ 0.19M 0M
Bluebird Bio BLUE:US $ 0.74M 0.02M
Esperion Therapeutics ESPR:US $ 65K 4K
Exelixis EXEL:US $ 0.32M 0M
Halozyme Therapeutics HALO:US $ 0.14M 0M
Intercept Pharmaceuticals ICPT:US $ 0.03M 0M
Mirati Therapeutics MRTX:US $ 0.06M 0M
Moderna Inc MRNA:US 39.2K 800
Nektar Therapeutics NKTR:US $ 0.02M 0M
Neurocrine Biosciences NBIX:US $ 0.1M 0M
Novartis NOVN:VX SF 890M 11M
Ptc Therapeutics PTCT:US $ 0.07M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
Vertex Pharmaceuticals VRTX:US $ 2.6M 0M